What Are The Clinical Considerations And Risks Of Lower Face Rejuvenation With Neurotoxins And Laser Resurfacing?

Lower face rejuvenation requires restraint and correct treatment matching. Neurotoxins can soften dynamic lines caused by hyperactive muscles, but lower facial muscles are highly functionally important and often more sensitive than upper-face muscles. Treatment therefore demands conservative dosing, precise anatomy, and realistic separation of what neurotoxins can improve from what laser resurfacing or other energy-based devices must address.

The safest strategy is usually muscle softening rather than complete immobilization, combined with resurfacing when skin texture, photoaging, or laxity is present. The main risks are unintended weakness, altered speech or smile, asymmetry, and treating structural aging with a modality that cannot correct it.

Match the Treatment to the Cause of Aging

Distinguish dynamic lines from structural change

Neurotoxins primarily reduce dynamic wrinkles and contour changes produced by repeated muscle contraction. Common lower-face targets may include the mentalis, orbicularis oris, and muscles contributing to a gummy smile.

Laser resurfacing and related energy-based devices address different problems, including photoaging, uneven texture, superficial wrinkles, and dermal remodeling. They do not replace volume restoration or correct every form of skin laxity.

Assess whether the patient needs more than neurotoxin

A patient with chin dimpling from mentalis activity may respond well to a carefully limited neurotoxin treatment. A patient whose primary concern is lax, photodamaged skin may gain little from toxin alone and may require resurfacing, tightening technology, or another structural treatment.

The clinical plan should identify whether the dominant problem is muscle activity, skin quality, volume loss, laxity, or a combination.

Manage the Functional Risks of Lower-Face Neurotoxins

Use conservative dosing

Lower facial muscles can respond strongly to neurotoxins. Excessive dosing may produce disproportionate weakness even when the visible treatment area is small.

The goal should be controlled reduction of hyperactivity, not total paralysis. Conservative initial treatment with reassessment is safer than attempting maximal correction at the first session.

Protect speech and oral function

Unintended diffusion or excessive weakening can affect activities that depend on precise lower-face muscle control. Potential functional effects include:

Difficulty enunciating words
Altered smiling or facial expression
Difficulty playing wind instruments
Changes in lip competence or perioral control
Visible asymmetry

These risks are particularly relevant around the mouth and chin, where small changes in muscle balance can become noticeable during speaking, eating, smiling, or playing an instrument.

Evaluate baseline asymmetry and muscle dependence

Before injection, document the patient’s resting symmetry, smile, speech, lip movement, chin contraction, and relevant muscle strength. Pre-existing asymmetry or compensatory muscle activity can become more apparent after treatment.

Patients who rely heavily on particular perioral muscles for professional speech, singing, wind-instrument performance, or facial expression require especially cautious counseling.

Understand What Laser Resurfacing Adds

Treat the skin rather than the muscle

Fractional or non-ablative laser systems can improve surface irregularity and stimulate collagen remodeling. More intensive resurfacing may address photoaging and fine surface rhytids, while radiofrequency and related systems may be considered when dermal tightening is part of the treatment objective.

The device must be selected according to skin type, degree of photoaging, laxity, downtime tolerance, and risk of pigmentary or wound-healing complications.

Use the combination for complementary effects

Neurotoxin reduces repetitive mechanical folding, while resurfacing improves the epidermal and dermal environment. In principle, reducing movement during healing may help limit repeated creasing while collagen remodeling occurs.

This is a complementary approach, not evidence that either treatment becomes universally more powerful or appropriate for every lower-face patient.

Plan Sequencing and Procedural Safety

Do not assume one sequence fits every case

The supplied clinical references describe both approaches: laser treatment before neurotoxin to minimize manipulation of newly placed toxin, and neurotoxin before or alongside resurfacing to reduce movement during healing. This apparent variation reflects differences in device type, treatment intensity, treatment location, and clinical protocol.

There is no single sequence that should be applied automatically. The treating clinician should follow the specific device instructions, injection protocol, tissue-healing considerations, and local regulatory guidance.

Consider laser intensity and tissue disruption

Non-ablative and fractional treatments generally involve different levels of thermal injury, inflammation, and recovery. Ablative fractional CO₂ or Erbium procedures require more stringent attention to wound care, infection prevention, barrier recovery, and timing of subsequent interventions.

The more disruptive the resurfacing procedure, the more important it is to avoid unnecessary manipulation of treated skin and to coordinate follow-up carefully.

Prevent cross-procedure complications

The protocol should account for:

Sterile technique and infection prevention
Skin-barrier disruption after resurfacing
Avoiding injection through actively inflamed, infected, or incompletely healed skin
Appropriate analgesia and eye protection where relevant
Clear post-treatment instructions
A plan for identifying and managing delayed complications

Laser resurfacing should not be treated as a cosmetic add-on without accounting for its own inflammatory and wound-healing risks.

Screen the Patient Before Treatment

Review anatomy, goals, and prior procedures

A complete assessment should include prior neurotoxin response, previous facial surgery or fillers, baseline asymmetry, neuromuscular history, skin sensitivity, pigmentation risk, scarring history, and the patient’s tolerance for downtime.

The patient’s desired outcome must also be clarified. “A smoother chin,” “less perioral wrinkling,” and “tighter skin” are different treatment objectives and may require different modalities.

Set realistic expectations

Neurotoxin effects are temporary and limited to muscle-driven components. Resurfacing can improve texture and photoaging but cannot guarantee correction of significant laxity or volume depletion.

Patients should understand that a combined plan may improve overall refinement without eliminating every wrinkle or restoring youthful facial structure.

Recognize the Main Trade-offs

Greater correction can increase functional risk

More toxin is not necessarily better in the lower face. Increasing the dose may reduce movement further but also raises the likelihood of weakness affecting speech, smiling, lip control, or symmetry.

A deliberately partial response is often preferable to an aggressive correction that produces an unacceptable functional change.

Combination treatment increases complexity

Using neurotoxin and resurfacing together may address more than one aging mechanism, but it also requires coordination of injection placement, energy settings, treatment timing, wound care, and follow-up.

The combined plan should be staged or modified when the patient’s skin condition, healing capacity, or functional risk makes simultaneous treatment inappropriate.

“Synergy” should not replace clinical judgment

Although reduced muscle movement may complement resurfacing, the benefit depends on accurate diagnosis and appropriate treatment intensity. Combining procedures cannot compensate for poor patient selection, excessive toxin dosing, incorrect laser settings, or inadequate aftercare.

Common Pitfalls to Avoid

Treating laxity with neurotoxin alone

Neurotoxins cannot tighten sagging skin, reverse dermal photoaging, or restore lost volume. Using them as a substitute for resurfacing or structural assessment can produce a weak appearance without solving the patient’s primary concern.

Overcorrecting perioral muscles

Perioral muscles have important functional roles. Treating them as if they were isolated wrinkle-producing muscles increases the chance of speech changes, altered lip function, and an unnatural smile.

Ignoring device-specific precautions

“Laser resurfacing” describes multiple technologies with different depths, thermal profiles, and recovery requirements. Safety decisions must be based on the actual device and treatment parameters, not on a generic assumption that all lasers behave alike.

Failing to document the baseline

Without photographs and functional assessment before treatment, it becomes difficult to distinguish a treatment-related change from pre-existing asymmetry or normal expression variability.

Making the Right Choice for Your Goal

A safe plan begins with determining whether the patient’s dominant problem is dynamic muscle activity, skin quality, laxity, volume loss, or a combination.

If your primary focus is dynamic lower-face lines: Use conservative, anatomically precise neurotoxin treatment aimed at softening muscle activity while preserving speech, smiling, and oral function.
If your primary focus is photoaging or surface texture: Prioritize an appropriately selected resurfacing protocol, with skin type, healing risk, and device-specific precautions assessed in advance.
If your primary focus is combined rejuvenation: Coordinate neurotoxin and energy-based treatment rather than assuming that simultaneous treatment or a fixed sequence is universally safest.
If your primary focus is professional facial function: Favor minimal dosing, detailed baseline assessment, and staged treatment with explicit counseling about temporary functional impairment.
If your primary focus is laxity or volume loss: Do not rely on neurotoxin or resurfacing alone; perform a broader structural assessment and select additional treatment only when clinically appropriate.

The safest lower-face rejuvenation plan is conservative, diagnosis-driven, device-specific, and designed to improve appearance without sacrificing function.

Summary Table:

Key Consideration	Clinical Implication
Distinguish dynamic vs. structural aging	Neurotoxins address dynamic lines; laser resurfacing addresses skin texture and photoaging.
Conservative dosing	Lower facial muscles are sensitive; overcorrection can impair speech and smile.
Protect oral function	Avoid weakening muscles essential for speech, eating, and expression.
Baseline documentation	Assess asymmetry and muscle function before treatment to manage expectations.
Complementary effects	Neurotoxin reduces movement during healing; laser improves skin quality.
Individualized sequencing	No fixed order; depends on device type, intensity, and clinical protocol.
Patient screening	Review prior procedures, skin type, and functional reliance on facial muscles.
Realistic expectations	Combination improves refinement but not sagging or volume loss.

Enhance your lower face rejuvenation practice with BELIS's advanced medical aesthetic devices. Our portfolio includes precision laser systems (Fractional CO₂, Erbium) and energy-based platforms designed for safe, effective skin resurfacing and tightening. Partner with BELIS to offer comprehensive, high-quality aesthetic solutions to your clinic. Contact us today to learn more about our OEM/ODM support and cutting-edge technology.